MarketCap
Facebook
X
TelegramOxford Immunotec Global PLC DSO Ratio 2011-2026 | OXFD
Annual DSO Ratio Oxford Immunotec Global PLC
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | 90.8 | 83.4 | 60.1 | 56.2 | 41 | 50.3 | 44.7 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 90.8 | 41 | 60.9 |
DSO Ratio of other stocks in the Diagnostics research industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
63.8 | $ 119.52 | -0.71 % | $ 36.3 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
31.7 | $ 20.48 | 2.97 % | $ 220 M |  China |
 |
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 17.68 | 0.28 % | $ 942 M | USA |
 |
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
94.7 | $ 1.41 | 2.18 % | $ 1.88 M | USA |
 |
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
49.2 | $ 24.57 | 0.82 % | $ 682 M | USA |
 |
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
65 | $ 181.55 | 1.25 % | $ 9 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 517.53 | -0.47 % | $ 14.9 B | USA |
 |
Interpace Biosciences
IDXG
|
66.9 | $ 2.2 | - | $ 9.73 M | USA |
 |
Danaher Corporation
DHR
|
55.3 | $ 197.46 | -0.54 % | $ 141 B | USA |
 |
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
61.3 | $ 132.48 | 1.66 % | $ 21.1 B | USA |
 |
Natera
NTRA
|
81.5 | $ 208.26 | -2.97 % | $ 20.5 B | USA |
 |
NeoGenomics
NEO
|
77.7 | $ 8.63 | 3.35 % | $ 1.11 B | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 16.19 | 1.06 % | $ 490 M | USA |
 |
Precipio
PRPO
|
21.1 | $ 28.71 | 0.74 % | $ 46.1 M | USA |
 |
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K |  Israel |
 |
Guardant Health
GH
|
46.1 | $ 84.85 | -1.79 % | $ 10.6 B | USA |
 |
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B |  Niderland |
 |
Myriad Genetics
MYGN
|
52.3 | $ 5.21 | 6.01 % | $ 482 M | USA |
 |
Anixa Biosciences
ANIX
|
275 | $ 2.89 | 0.35 % | $ 93.8 K | USA |
 |
Senseonics Holdings
SENS
|
10.3 | $ 6.87 | 1.78 % | $ 287 M | USA |
 |
Biomerica
BMRA
|
57.7 | $ 2.09 | -0.64 % | $ 4.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 116.45 | 3.0 % | $ 9.61 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 267.54 | -0.49 % | $ 22.3 B | USA |
 |
Soleno Therapeutics
SLNO
|
27 | $ 52.61 | -0.02 % | $ 2.67 B | USA |
 |
Neogen Corporation
NEOG
|
66.6 | $ 9.48 | -1.35 % | $ 2.06 B | USA |
 |
Lantheus Holdings
LNTH
|
80.5 | $ 83.57 | 1.0 % | $ 5.64 B | USA |
 |
Neuronetics
STIM
|
48.7 | $ 1.39 | -3.15 % | $ 91.7 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 191.67 | -1.23 % | $ 21.3 B | USA |
 |
ENDRA Life Sciences
NDRA
|
7.11 | $ 5.07 | 2.22 % | $ 3.99 M | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 530.89 | 0.68 % | $ 200 B | USA |